HC Wainwright & Co. Maintains Buy on Instil Bio, Adjusts Price Target To $18
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has maintained a Buy rating on Instil Bio (NASDAQ:TIL) and significantly increased the price target from $2 to $18.
January 22, 2024 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Instil Bio's stock may see a positive short term impact due to the maintained Buy rating and substantial increase in price target from $2 to $18 by HC Wainwright & Co.
The substantial increase in the price target for Instil Bio by a reputable analyst firm like HC Wainwright & Co. typically signals a strong vote of confidence in the company's prospects, which can lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100